The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Reiterates India’s commitment to the BRICS TB Research Network Initiative
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Subscribe To Our Newsletter & Stay Updated
